Pranjal Gambhir Joins Lazard as Head of Medical Technology

Rhea-AI Summary

Lazard (LAZ) has hired Pranjal Gambhir as head of Medical Technology, based in New York. He will lead coverage of medical technology companies and advise clients on strategy and corporate development transactions across the sector.

Gambhir was most recently a managing director at Citi, covering companies across multiple medical technology subsectors. He spent 20 years at Citi in roles in New York and New Delhi. Lazard said his arrival deepens the coverage its Healthcare Group can offer clients.

Argus Sep 28 session 3 alerts

-2.53% close to close 1.1x rel. volume Open Argus

Details

News Market Reaction – LAZ

$3.49B Mkt Cap at Peak Alert

On Sep 28, the day this news came out, LAZ closed 2.53% below the previous close. Our momentum scanner recorded 3 alerts in the available session data.

Data tracked by StockTitan Argus for the Sep 28 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) announced today that Pranjal Gambhir joined the firm as Head of Medical Technology, based in New York.

In this role, Pranjal will lead coverage of Medical Technology companies, advising clients on strategy and corporate development transactions across the sector.

"Pranjal has broad and deep experience across the Medical Technology sector, and his arrival deepens the coverage we can offer clients," said David Gluckman, Global Head of Healthcare at Lazard. "His background across multiple sub-sectors gives our Healthcare Group added strategic depth as we continue to grow our practice."

Pranjal joins Lazard from Citi, where he was most recently Managing Director covering Medical Technology companies across multiple sub-sectors. He spent 20 years at Citi across various roles in New York and New Delhi.

"The Medical Technology sector continues to evolve rapidly, creating both opportunity and complexity for clients," said Pranjal Gambhir. "Lazard's independent perspective and global platform are exactly what leadership teams, boards and investors need, and I look forward to helping them navigate what's ahead. "

Pranjal earned his MBA from the Indian School of Business and Bachelor of Commerce from Delhi University.

Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Lazard is listed on the New York Stock Exchange as Lazard, Inc. under the ticker LAZ. For more information, please visit Lazard.com and follow Lazard on LinkedIn.

Media Relations         
Jessica Francisco
+1 212-632-6571
jessica.francisco@lazard.com

Shannon Houston
+1 212-632-6880                   
shannon.houston@lazard.com

Investor Relations
William Murdock
+1 212-632-1564
william.murdock@lazard.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pranjal-gambhir-joins-lazard-as-head-of-medical-technology-302891151.html

SOURCE Lazard

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is Lazard's new head of Medical Technology?

Pranjal Gambhir joined Lazard as head of Medical Technology, based in New York. He will lead coverage of companies in the sector and advise clients on strategy and corporate development transactions.